Type
Business expansion
Country
Germany
Region
Bayern; Oberbayern; Pfaffenhofen a. d. Ilm
Location of affected unit(s)
Pfaffenhofen an der Ilm
Sector
Manufacturing
(20 - 21) Manufacture of chemicals and pharmaceuticals
21.2 - Manufacture of pharmaceutical preparations
21.2 - Manufacture of pharmaceutical preparations

350 jobs
Number of planned job creations
Job creation
Announcement Date
6 July 2026
Employment effect (start)
6 July 2026
Foreseen end date
31 December 2030

Description

Daiichi Sankyo, a Japanese pharmaceutical company, announced the creation of at least 350 new jobs as part of a €1 billion investment to expand its oncology manufacturing facility in Pfaffenhofen an der Ilm, Bavaria. The expansion is expected to be fully operational by the end of 2030.

The investment is driven by the need to strengthen global supply chains for complex cancer therapies and to establish a reliable manufacturing base in Germany amid intense international competition.

Daiichi Sankyo employs approximately 3,300 people.


Citation

Eurofound (2026), Daiichi Sankyo, Business expansion in Germany, factsheet number 300715, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/300715.